Related Experiment Video
Updated: Jan 28, 2026

Author Spotlight: Quantifying Siderophores and Pyochelin for Infection Control
Published on: March 15, 2024
Specific type IV pili groups in clinical isolates of Pseudomonas aeruginosa
Gertrudis Horna1,2, Karina Quezada3, Susan Ramos3
1Barcelona Institute for Global Health, ISGlobal, Hospital Clínic - Universitat de Barcelona, building CEK, C/Rosselló 149-153, 08036, Barcelona, Spain. gertrudis.horna@isglobal.org.
Abstract:
The relationships between specific type IV pili (TFP) groups and antibiotic resistance, biofilm formation, and bacterial motility were determined in 190 Pseudomonas aeruginosa clinical isolates. While motility and biofilm formation were determined by phenotypic assays, the presence of TFP was determined by PCR assay and antibiotic susceptibility by disk diffusion. The results showed a high ability to form biofilm (97.4%), multidrug resistance (44.7%), and the presence of a high number of motile isolates. We also found an association between strong biofilm production and multidrug resistance. Furthermore, TFP group III was associated with strong biofilm production. In contrast, the isolates with TFP group II and those without any TFP were associated with non-strong biofilm production. Regarding motility, TFP group II was associated with higher percentages of swarming, swimming, and twitching, while TFP group I showed lower percentages of swarming and twitching, and TFP group III showed lower levels of swarming and swimming. In conclusion, these findings highlight the differences in P. aeruginosa phenotypes related to the presence of specific TFP groups and their potential implications in clinical settings.
Insights
Specific type IV pili (TFP) groups influence Pseudomonas aeruginosa biofilm formation and motility. TFP group III correlates with strong biofilm production and multidrug resistance in clinical isolates.
Area of Science:
- Microbiology
- Bacterial Genetics
Background:
- Pseudomonas aeruginosa is an opportunistic pathogen known for its adaptability.
- Type IV pili (TFP) are crucial for various bacterial surface-associated behaviors.
- Understanding TFP roles in virulence factors like biofilm and motility is clinically relevant.
Purpose of the Study:
- To investigate the association between specific TFP groups and key P. aeruginosa phenotypes.
- To determine the relationship between TFP, antibiotic resistance, biofilm formation, and motility in clinical isolates.
Main Methods:
- Phenotypic assays for biofilm formation and motility.
- Polymerase Chain Reaction (PCR) for TFP detection.
- Disk diffusion method for antibiotic susceptibility testing.
- Analysis of 190 clinical P. aeruginosa isolates.
Main Results:
- High prevalence of biofilm formation (97.4%) and multidrug resistance (44.7%) observed.
- Strong biofilm production was associated with multidrug resistance.
- TFP group III linked to strong biofilm production; TFP group II and absence of TFP linked to weaker biofilm formation.
- Distinct motility patterns observed: TFP group II associated with increased swarming, swimming, and twitching; TFP groups I and III showed reduced motility.
Conclusions:
- Specific TFP groups significantly modulate P. aeruginosa biofilm production and motility.
- TFP group III is associated with enhanced biofilm formation and multidrug resistance.
- Findings underscore the clinical significance of TFP diversity in P. aeruginosa pathogenesis.
Related Concept Videos
Type IV Collagen of Basal Lamina
A type IV collagen molecule has six alpha chains which can...
Fimbriae, Pili, and Axial Filaments
Clinically Relevant Drug Product Specifications: Methods of Establishment
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

